AbbVie, one of the two U.S. firms bringing an injunction against Europe's drugs regulator over the issue of trial data secrecy, said on Thursday it had withdrawn its lawsuit. AbbVie, a pharmaceutical company, had sought an injunction in March last year to block Europe's medicines regulator from releasing "confidential" and "commercially-sensitive" information on its blockbuster rheumatoid arthritis drug. AbbVie said on Thursday the European Medicines Agency had accepted a new set of redacted documents submitted by the company, along with the company's rationale for removing certain confidential information. The lawsuit against AbbVie and another U.S. drugmaker InterMune had turned into a high-profile fight over drug trial data. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment